Clinical Trial Update: Combination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric Cancer [Phase 2]

View source ↗

Summary

This clinical trial investigates a combination of Nimotuzumab, Capecitabine, and radiotherapy for inoperable or recurrent gastric cancer in Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Gastric Cancer, Concurrent Chemoradiotherapy | Phase 2 | Status: UNKNOWN